Long-Term Survival of Patients With Chemotherapy-Naïve Metastatic Nasopharyngeal Carcinoma Receiving Cetuximab Plus Docetaxel and Cisplatin Regimen

Purpose: Metastatic nasopharyngeal carcinoma (mNPC) remains incurable. This prospective study aimed to investigate whether adding cetuximab to cisplatin-based induction therapy could improve efficacy and survival for chemotherapy-naïve mNPC patients. Patients and Methods: Eligible chemotherapy-naïve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Zhang, Mengping, Huang, He, Li, Xueying, Huang, Ying, Chen, Chunyan, Fang, Xiaojie, Wang, Zhao, Guo, Chengcheng, Lam, Sioteng, Fu, Xiaohong, Hong, Huangming, Tian, Ying, Lu, Taixiang, Lin, Tongyu
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7319102/
https://ncbi.nlm.nih.gov/pubmed/32637360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados